
    
      Comparison of 2 revaccination strategies in randomized HIV-infected patients with T CD4 cell
      count above 200/mm3

      Intervention:

        1. Arm A: GenHevac-B® 20μg IM at M0, M1, M6

        2. Arm B: GenHevac-B® 40μg IM at M0, M1, M6
    
  